Q1 2023 Holdings
Filed 2023-05-12 | 44 holdings | $147.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics Inc | COM | 48576A100 | $41.0M | 225,688 | 27.9% |
| Illumina Inc(ILMN) | COM | 452327109 | $27.7M | 119,196 | 18.9% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $12.0M | 368,665 | 8.2% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $9.5M | 47,096 | 6.5% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $4.8M | 651,100 | 3.3% |
| Exscientia PLC | ADS | 30223G102 | $4.6M | 859,892 | 3.1% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $4.3M | 1,696,558 | 2.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.1M | 114,380 | 2.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $3.3M | 189,339 | 2.3% |
| Merus N V | COM | N5749R100 | $2.8M | 151,000 | 1.9% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $2.7M | 111,984 | 1.9% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $2.6M | 113,950 | 1.8% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.6M | 12,022 | 1.8% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $2.5M | 493,584 | 1.7% |
| Incyte Corp(INCY) | COM | 45337C102 | $2.5M | 34,391 | 1.7% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $1.9M | 60,000 | 1.3% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $1.6M | 1,166,952 | 1.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $1.6M | 136,655 | 1.1% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $1.6M | 613,223 | 1.1% |
| Gitlab Inc(GTLB) | CLASS A COM | 37637K108 | $1.3M | 36,952 | 0.9% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.2M | 64,200 | 0.8% |
| Mercadolibre Inc(MELI) | COM | 58733R102 | $1.2M | 904 | 0.8% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $1.1M | 73,582 | 0.7% |
| Aerovate Therapeutics Inc | COM | 008064107 | $966.9K | 47,936 | 0.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $701.6K | 7,215 | 0.5% |
| Eargo Inc | COM NEW | 270087208 | $692.2K | 147,904 | 0.5% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $636.4K | 34,106 | 0.4% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $626.9K | 370,950 | 0.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $618.7K | 78,720 | 0.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $580.2K | 32,520 | 0.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $575.9K | 25,606 | 0.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $564.3K | 29,984 | 0.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $532.8K | 1,430 | 0.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $446.9K | 4,168 | 0.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $286.4K | 1,182 | 0.2% |
| Affimed N V | COM | N01045108 | $277.7K | 372,472 | 0.2% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $189.6K | 41,950 | 0.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $148.8K | 17,847 | 0.1% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $124.3K | 177,900 | 0.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $121.7K | 19,622 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $102.1K | 11,500 | 0.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $94.4K | 12,521 | 0.1% |
| Cerus Corp(CERS) | COM | 157085101 | $42.1K | 14,172 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $15.3K | 11,337 | 0.0% |